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Edited by Christian GriesingerAbstract Calbindin-D28k is known to function as a calcium-
buﬀering protein in the cell. Moreover, recent evidence shows
that it also plays a role as a sensor. Using circular dichroism
and NMR, we show that calbindin-D28k undergoes signiﬁcant
conformational changes upon binding calcium, whereas only min-
or changes occur when binding target peptides in its Ca2+-loaded
state. NMR experiments also identify residues that undergo
chemical shift changes as a result of peptide binding. The subse-
quent use of computational protein–protein docking protocols
produce a model describing the interaction interface between cal-
bindin-D28k and its target peptides.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Modeling1. Introduction
Calcium is ubiquitous throughout the body, mediating many
diverse cellular processes. Calcium signaling pathways are
widely distributed and participate in all basic cellular func-
tions, playing a key role in homeostasis [1–3]. Calcium regula-
tion and signaling is achieved through interaction with an
assortment of proteins known as calcium binding proteins
(CaBPs). CaBPs have traditionally been distinguished by the
role they play in the cell, as either calcium buﬀers (buﬀering
and transport) or as calcium sensors (interactions with target
proteins) [4].
Calbindin-D28k (261 residues, 30 kDa) is a member of the
calmodulin superfamily of intracellular Ca2+-binding proteins
[3]. It plays roles in protecting against excitotoxic cell death
in hippocampal neurons, and in transcellular Ca2+ movement
in intestinal absorptive cells and kidney distal tubules [5–7].
Calbindin-D28k also controls insulin release in pancreatic islet
cells and co-localizes and interacts with the plasma membrane
Ca2+ pump in the nervous system [6,8]. Early studies suggested
that calbindin-D28k functioned solely as a calcium buﬀer [9].
However, it has now been established that it also exhibits cal-
cium sensor properties [10–15]. Calbindin-D28k undergoes a
structural transition from an ordered apo-conformation,
through a disordered partially Ca2+-loaded state, to a highly*Corresponding author. Fax: +1 919 515 2057.
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doi:10.1016/j.febslet.2007.09.004structured fully Ca2+-loaded state [16]. Additionally, it has
been shown that Ca2+-loaded calbindin-D28k directly interacts
with at least three target proteins, Ran-binding protein M
(RanBPM), myo-inositol monophosphatase (IMPase), and
caspase-3/procaspase-3 [10,11,13]. These observations suggest
that it performs crucial functions as a sensor protein. RanBPM
is a protein that regulates many functions, including the activ-
ity of GTP-bound Ran and microtubule assembly in cells [10].
IMPase is a key enzyme in the phosphatidylinositol second-
messenger pathway. Calbindin-D28k also modulates apoptosis
by binding caspase-3 and altering its activity in osteoblasts
that mineralize bone [12,13,15]. There is an extra interest
in calbindin-D28K/(pro)caspase-3 interactions in the onset of
neurodegenerative diseases, where calbindin-D28k acts as a
neuroprotector [17,18]. Caspases exist as inactive zymogens
(procaspases) and become activated by proteolysis. In the case
of caspase-3, the pro-domain is processed and cleaved to opti-
mize active site positioning. If the processing and cleavage of
the pro-domain is hampered, caspase-3 activity is aﬀected [19].
Consequently, elucidating calbindin-D28k’s sensor charac-
teristics and identifying target peptide binding surfaces may
assist in the development of new therapeutic approaches for
the treatment of several disorders. Initial studies showed that
homologous peptide sequences from RanBPM, IMPase
and the pro-domain of procaspase-3 bound to Ca2+-loaded
calbindin-D28k. These peptide sequences are: LASIKNR
(RanBPM), ISSIKEKYPSHS (IMPase), and SKSIKNLEP
(procaspase-3) [20].
Here, we used circular dichroism (CD) and NMR chemical
shift perturbations (CSP) to analyze the complexes between
these three peptides and calbindin-D28k. CD experiments re-
vealed that no major structural changes occurred upon target
peptide binding and CSP studies showed that the protein/pep-
tide interactions were speciﬁc. CSP identiﬁed calbindin-D28k
residues involved in peptide binding. Residues deﬁned as
‘active’ through CSP were used as restraints in the molecular
protein–protein docking program HADDOCK to model the
protein/peptide interactions between calbindin-D28k and Ran-
BPM, IMPase, and caspase-3. This docking analysis revealed a
contiguous target binding surface in the region of EF-hand 2.2. Materials and methods
2.1. Sample preparation
Cloning, expression, and puriﬁcation protocols for Rattus norvegicus
calbindin-D28k have been described [16]. Peptides used in the NMR
titrations and CD experiments are as follows: RanBPM (LASIKNR),blished by Elsevier B.V. All rights reserved.
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Genosys), and a negative control C28R2 (LRRGQILWFRGLN-
RIQTQIRVVKAFRSS) (AnaSpec).
2.2. Circular dichroism
CD spectra were measured using a PiStar Kinetic Circular Dichroism
Spectrometer using a 1 cm (near-UV) Hellma cuvette (Hellma Corp.).
Measurements were corrected for background and peptide signal. Buf-
fer conditions were subtracted under the same experimental conditions.
Spectra were recorded in 10 mM Tris pH 6.25, and 1 mM CaCl2 for
Ca2+-loaded calbindin-D28k samples and 10 mM Tris pH 6.25 and
1 mM EDTA for apo-calbindin-D28k samples. Protein/peptide com-
plexes were combined at 1:1, 1:4, 1:8, 1:12, 1:16 ratios and calbindin-
D28k concentration was held at 60 lM. Complexes were incubated
overnight at room temperature prior to CD analysis. Spectra were
recorded ﬁve times and averaged at 25 ± 1.0 C from 250 to 320 nm.
2.3. NMR peptide titrations
NMR samples contained 0.5 mM Ca2+-loaded calbindin-D28k
(pH 6.2, 10 mM Tris, 1 mM DTT, 0.02% (w/v) NaN3, 3 mM CaCl2,
and 10% (v/v) D2O). Peptides from RanBPM, IMPase, procaspase-3,
and the negative control C28R2 were titrated into samples in incre-
ments that provided the following peptide/protein molar ratios: 0:1,
1:1, 2:1, 4:1, 8:1, and 16:1. At each titration point, a 1H–15N HSQC-
TROSY experiment was collected at 25 C on a Varian Inova
600 MHz spectrometer using a 1H/13C/15N triple-resonance Z-gradient
probe. Data were processed using NMRPipe and analyzed using
NMRView [21,22].Fig. 1. Near-UV circular dichroism spectra. (A) comparison of apo calb
conformational change. Spectra of calbindin-D28k alone (black) and with 1:1
and (D) procaspase-3. No gross conformational changes occur upon peptide2.4. High ambiguity driven protein–protein docking (HADDOCK)
The coordinate ﬁle for Ca2+-loaded calbindin-D28k, was obtained
from the RCSB Protein Data Bank (PDB, 2G9B) [23]. The coordinate
ﬁles for peptides RanBPM, IMPase, and procaspase-3, were generated
using PYMOL (http://pymol.sourceforge.net). Protein residues located
in the predicted interaction interface were deﬁned as ‘active’. These
assignments were based on CSP data generated via NMR protein/pep-
tide titrations. All active residues exhibit a relative solvent accessibility
>30% as delineated by the program NACCESS [24]. The following res-
idues were deﬁned as active: S4, H5, Q7, I11, T12, E18, E57, I73, G74,
I75, A79, V81, E86, L89, R93, Q96, S99, C100, L153, and L180. For
each peptide all residues were classiﬁed active. No residues in the pro-
tein were deﬁned as being ‘passive’ (residues with solvent accessibility
>30% surrounding active residues identiﬁed from CSP data). Default
HADDOCK parameters were used in the docking procedure. Final
structures were grouped using a minimum cluster size of 40 and an
RMSD <3 A˚ using the program ProFit (http://www.bioinf.org.uk/soft-
ware/proﬁt/). The resulting clusters were analyzed and ranked accord-
ing to their average interaction energies.3. Results
3.1. Circular dichroism
Calbindin-D28k has been shown by NMR to undergo a
large conformational change upon sequential calcium binding
[16]. CD was used to investigate the structural transitions thatindin-D28k (red) with Ca2+-loaded calbindin-D28k showing a large
6 ratio of calbindin-D28k:peptide (red) using (B) IMPase (C) RanBPM,
binding.
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loaded and apo-calbindin-D28k are shown in Fig. 1A. In
agreement with previous studies, a major conformational
change is seen, with the main diﬀerences in the tryptophan
region (280 nm) indicating a La-band transition [25].
The near-UV CD spectrum of Ca2+-loaded calbindin-D28k
was monitored during serial titrations with the synthesized
peptides up to a 16:1 peptide:protein molar ratio, in order to
investigate whether changes occur upon binding. No major
conformational changes were observed as calbindin-D28k
bound the peptides (Fig. 1B–D). Subtle diﬀerences were iden-
tiﬁed (in the region of the spectrum commonly attributed to
phenylalanine absorption, 260 nm), indicative of ligand bind-
ing and slight alterations of the tertiary structure [26].
3.2. NMR peptide titrations
The RanBPM, IMPase, and procaspase-3 peptides were
titrated into Ca2+-loaded calbindin-D28k. Chemical shift
changes and line broadening were monitored via 1H–15N
HSQC-TROSY experiments (Fig. 2). These perturbations were
quantiﬁed by calculating the cumulative chemical shift
(Ddppm) where:
Ddppm ¼ ½Ddð1HÞ2 þ 0:1Ddð15NÞ21=2 ð1Þ
Dd(1H) is the proton chemical shift change and Dd(15N) is the
nitrogen chemical shift change. Upon addition of the individ-
ual peptides some residues undergo little to no chemical shift,
such as R249, E210, and L54 (<0.05 ppm). Other residues
experience larger changes, e.g. L43 and E86 (>0.20 ppm)
(Fig. 2A–C). In each titration, calbindin-D28k residues show
similar overall chemical shift changes, although the extent of
shift and direction varies slightly from peptide to peptide. This
indicates a similar binding response for all ligands studied.Fig. 2. Peptide titrations of calcium loaded calbindin-D28k. (A–D) Selected r
target peptides from (A) RanBPM (B) IMPase (C) procaspase-3 and (D) C
(black), 1:1 (red), 2:1 (magenta), 4:1 (blue), 8:1 (cyan), and 16:1 (green).The regions of calbindin-D28k showing notable chemical
shift changes were: A2–T12, E18, E57, K72–F117, L130–
N135, L153–D155, K161–I184, E220–L226, and I255-N261.
Two classes of chemical shifts are apparent in this group.
The ﬁrst class, A2–T12, E18, E57, L130–N135, L153–D155,
K161–I184, E220–L226, and I255–N261, includes resi-
dues which undergo large chemical shift changes (Ddppm >
0.20 ppm). The second class, K72–F117 involves a subset of
residues that experience chemical shift changes and/or line
broadening, indicative of conformational exchange. In order
to determine if the interaction with the target peptides was spe-
ciﬁc, a negative control peptide was designed (C28R2). This
peptide corresponds to the C-terminal tail of PMCA, a known
calmodulin target [27]. Titration of this peptide into Ca2+-
loaded calbindin-D28k resulted in no chemical shift changes
(Fig. 2D). This indicates that the binding observed for the pep-
tides of interest is speciﬁc and not a result of non-speciﬁc inter-
actions.
3.3. HADDOCK modeling
Areas within calbindin-D28k that undergo signiﬁcant chem-
ical shift perturbations with chemical shifts on average
>0.20 ppm upon peptide binding were used as a basis for deter-
mining active interface residues in the calbindin-D28k:peptide
complexes. For each modeling procedure, a series of ambigu-
ous interaction restraints were generated based on CSP data
and used in conjunction with the coordinate ﬁles for Ca2+-
loaded calbindin-D28k and the respective peptides. The dock-
ing procedure consists of three stages: rigid body energy
minimization, semi-ﬂexible reﬁnement with simulated anneal-
ing, and explicit water reﬁnement. The result of the docking
protocol is 200 reﬁned protein:peptide complexes, which were
subsequently clustered as a function of their backbone RMSDegions of 1H–15N HSQC-TROSY spectra of calbindin-D28k binding to
28R2 control. Spectra were collected at peptide:protein ratios of 0:1
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sulted in two clusters, arising from two possible linear orienta-
tions of the peptide. For each peptide studied the lowest energy/
best solution cluster maps to the same region of calbindin-
D28k, consisting of a3/a4 of EF-hand 2 (EF-2), a8 of EF-4,
and aA in the linker region between EF-2 and EF-3. The nature
of the interaction is exempliﬁed by the IMPase peptide–calbin-
din-D28k complex in Fig. 3A. The average total interaction
energy for each model is 11812 ± 112 kcal/mol1 (IMPase),
11512 ± 99 kcal/mol1 (RanBPM), and 11643 ± 117 kcal/
mol1 (procaspase-3). These structures have an average buried
surface energy of 1983 ± 90 A˚2, 1446 ± 63 A˚2, and 1666 ±
73 A˚2, respectively. Detailed structure statistics are given in
Supplementary materials (Table 1). Analysis of the interaction
interface from the 20 best structures taken from the lowest
energy cluster identiﬁes potential intermolecular hydrogen
bonds for each complex. For example, seven potential hydro-
gen bonds were identiﬁed in the IMPase low energy cluster,
consisting of Q7:S12, S8:S12, R47:S12, R93:E6, Q96:S3,
V173:S3, and E175:I1 with respect to calbindin-D28k:IMPase
(Fig. 3B). A full list of potential hydrogen bonds for all calbin-Fig. 3. HADDOCK modeling of IMPase peptide. (A) Model of Ca2+-
loaded calbindin-D28k bound to IMPase peptide (lowest energy model
from cluster 2) displayed as a PyMOL surface plot. EF-hands from
calbindin-D28k colored EF-1 (red) EF-2 (orange) EF-3 (green), EF-4
(yellow), EF-5 (blue), EF-6 (magenta). (B) Same surface plot with
residues from calbindin-D28k involved in hydrogen bonding (Q7, S8,
R47, Q96, R93, V173, and E175) colored yellow with F61 and F92
highlighted in red.din-D28k:peptide complexes is provided in Supplementary
material (Table 2). Further analysis of the protein:peptide
interface reveals two nearby aromatic residues: F92 and F61
(See Fig. 3B). Perturbation of these residues likely accounts
for the phenylalanine absorption changes observed in the CD
spectrum of the calbindin-D28k:peptide titrations.4. Discussion
Calcium binding proteins are key elements of cellular signal-
ing and calcium homeostasis. Variations in the conformational
response to calcium binding are indicators of the role of these
proteins as either buﬀers or sensors. Calcium buﬀers typically
exhibit little to no structural perturbations upon calcium bind-
ing, allowing for their high buﬀering capacity and structural
stability. Conversely, calcium signaling proteins typically un-
dergo large conformational changes in response to calcium,
exposing a hydrophobic patch which allows for downstream
protein/protein interactions. Earlier work in this laboratory
demonstrated that apo-calbindin-D28k adopts an ordered con-
formation that changes signiﬁcantly upon calcium loading.
Here we report detailed information concerning the structural
perturbations associated with the interaction between Ca2+-
loaded calbindin-D28k and peptides derived from three of its
protein targets and use molecular modeling to describe a mod-
el for the interaction interface.
Elucidation of the high resolution structure of Ca2+-loaded
calbindin-D28k has allowed for a more thorough analysis of
its interactions with peptides derived from RanBPM, IMPase,
and procaspase-3. CD was used to monitor changes in tertiary
conformation, as UV absorption/emission bands of aromatic
amino acid side chains are visible in this spectrum. Only very
minor changes in the conformation of Ca2+-loaded calbin-
din-D28k are seen upon titration with peptides, in contrast
to the large changes seen upon addition of calcium (Fig. 1).
Peptide titration did result in perturbation of phenylalanine
residue signal absorption, which typically has a strong compo-
nent around 260 nm.
Protein/peptide NMR titrations were used to identify resi-
dues that are directly involved in and proximal to the binding
interface. Because the chemical environment surrounding resi-
dues is aﬀected by chemical bonding and molecular conforma-
tions, the CSP resulting from titration with the peptide can be
used as a marker to identify residues that are actively involved
in peptide binding. Similar chemical shift changes undergone
by residues in the presence of peptides derived from RanBPM,
IMPase, and procaspase-3 indicate that all three targets bind
to the same site. Molecular modeling of these complexes iden-
tiﬁed the protein:peptide interaction site as a3/a4 of EF-hand 2
(EF-2), a8 of EF-4, and aA in the linker region between EF-2
and EF-3.
Particularly interesting is that the protein–peptide interac-
tion is dominated by the EF2-aA region. EF2 does not bind
Ca2+ and NMR H/N linewidths for residues in this region
are 15% broader than their counterparts in EF1. Also, the
RMSD of the aA segment of calbindin-D28k (residues 82–
100) is the highest in the protein (1.7 A˚). These two pieces of
information imply that the EF2-aA section of the protein
shows conformational ﬂexibility. Such ﬂexibility may enable
this single region to accommodate the multiple, diﬀerent
4782 D.R. Kordys et al. / FEBS Letters 581 (2007) 4778–4782binding partners known to interact with calbindin-D28k.
Finally, since the EF2-aA region is not involved in calcium
binding, it may be possible for calbindin-D28k to perform its
buﬀering and signaling roles simultaneously.
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